Literature DB >> 24804717

Insights from the First International Conference on Hyperacusis: causes, evaluation, diagnosis and treatment.

Hashir Aazh1, Don McFerran, Richard Salvi, Deepak Prasher, Margaret Jastreboff, Pawel Jastreboff.   

Abstract

The First International Conference on Hyperacusis gathered over 100 scientists and health care professionals in London, UK. Key conclusions from the conference included: (1) Hyperacusis is characterized by reduced tolerance of sound that has perceptual, psychological and social dimensions; (2) there is a growing awareness that children as well as adults experience symptoms of hyperacusis or misophonia; (3) the exact mechanisms that give rise to hyperacusis are not clear, but the available evidence suggests that functional changes within the central nervous system are important and in particular, hyperacusis may be related to increased gain in the central auditory pathways and to increased anxiety or emotional response to sound; (4) various counseling and sound therapy approaches seem beneficial in the management of hyperacusis, but the evidence base for these remains poor.

Entities:  

Mesh:

Year:  2014        PMID: 24804717     DOI: 10.4103/1463-1741.132100

Source DB:  PubMed          Journal:  Noise Health        ISSN: 1463-1741            Impact factor:   0.867


  28 in total

1.  Effects of Acoustic Environment on Tinnitus Behavior in Sound-Exposed Rats.

Authors:  Aikeen Jones; Bradford J May
Journal:  J Assoc Res Otolaryngol       Date:  2018-01-02

2.  Audiological and Other Factors Predicting the Presence of Misophonia Symptoms Among a Clinical Population Seeking Help for Tinnitus and/or Hyperacusis.

Authors:  Hashir Aazh; Mercede Erfanian; Ali A Danesh; Brian C J Moore
Journal:  Front Neurosci       Date:  2022-07-05       Impact factor: 5.152

3.  Suppression and facilitation of auditory neurons through coordinated acoustic and midbrain stimulation: investigating a deep brain stimulator for tinnitus.

Authors:  Sarah J Offutt; Kellie J Ryan; Alexander E Konop; Hubert H Lim
Journal:  J Neural Eng       Date:  2014-10-13       Impact factor: 5.379

4.  Interaction of auditory and pain pathways: Effects of stimulus intensity, hearing loss and opioid signaling.

Authors:  Senthilvelan Manohar; Henry J Adler; Kelly Radziwon; Richard Salvi
Journal:  Hear Res       Date:  2020-06-04       Impact factor: 3.208

Review 5.  Misophonia: current perspectives.

Authors:  Andrea E Cavanna; Stefano Seri
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-18       Impact factor: 2.570

6.  Tinnitus and hyperacusis involve hyperactivity and enhanced connectivity in auditory-limbic-arousal-cerebellar network.

Authors:  Yu-Chen Chen; Xiaowei Li; Lijie Liu; Jian Wang; Chun-Qiang Lu; Ming Yang; Yun Jiao; Feng-Chao Zang; Kelly Radziwon; Guang-Di Chen; Wei Sun; Vijaya Prakash Krishnan Muthaiah; Richard Salvi; Gao-Jun Teng
Journal:  Elife       Date:  2015-05-12       Impact factor: 8.140

7.  Investigating a new neuromodulation treatment for brain disorders using synchronized activation of multimodal pathways.

Authors:  Craig D Markovitz; Benjamin T Smith; Cory D Gloeckner; Hubert H Lim
Journal:  Sci Rep       Date:  2015-03-25       Impact factor: 4.379

8.  Efficacy of Multi-Modal Migraine Prophylaxis Therapy on Hyperacusis Patients.

Authors:  Mehdi Abouzari; Donald Tan; Brooke Sarna; Yaser Ghavami; Khodayar Goshtasbi; Erica M Parker; Harrison W Lin; Hamid R Djalilian
Journal:  Ann Otol Rhinol Laryngol       Date:  2019-12-01       Impact factor: 1.547

9.  Validation of Screening Questions for Hyperacusis in Chronic Tinnitus.

Authors:  Martin Schecklmann; Astrid Lehner; Winfried Schlee; Veronika Vielsmeier; Michael Landgrebe; Berthold Langguth
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

10.  Tinnitus and hyperacusis therapy in a UK National Health Service audiology department: Patients' evaluations of the effectiveness of treatments.

Authors:  Hashir Aazh; Brian C J Moore; Karen Lammaing; Mark Cropley
Journal:  Int J Audiol       Date:  2016-05-19       Impact factor: 2.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.